"Moody’s Investor Services thinks these are just the start, with M&A activity expected to remain high over the next year to 18 months. Pharmas are trying to restock their pipelines due to approaching patent cliffs and long-term pricing pressure"........
Bring on the auction action.....starting point with one Phase 2 positive result would have to be $50 / share ? ...and thereon upwards...
Merck to acquire Prometheus in a US$ 10.8 b deal, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.28 |
Change
0.080(0.56%) |
Mkt cap ! $1.777B | |||
| Open | High | Low | Value | Volume |
| $14.22 | $14.55 | $14.10 | $4.611M | 320.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6352 | $14.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.38 | 4000 | 1 |
View Market Depth
| Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |